U.S. jury orders Takeda to pay $6 billion over Actos claims
A jury ordered takeda pharmaceutical co., LTD pay 6 yuan billion loss over claims that its mask their Actos diabetes drugs related to the risk of cancer, the plaintiff's lawyer said on Tuesday.
A lot of awards, met with in the crowded lafayette, Louisiana, the court was "shocked silence", the plaintiff's lawyer, mark lanier said.
Lilly, takeda's co-defendant, was ordered to pay $3 billions of punitive damages.
Takeda, Japan's largest pharmaceutical company, said it doesn't agree with ruling will powerfully challenge it, including motion after trial and appeal.
Takeda company's share price fell by 8.8%, to 4396 yen after the verdict, reached an eight-month low, and marks the biggest one-day drop in nearly five years.
Lanier admit that this is not sure if damages will continue for the legal process continues.
"No one go out to buy a new home," he told Reuters.
"This is a conservative judges and a conservative court, she was' balls and strikes," we are not in any grand illusion. "
He added that the judge judgment motion soon after to without putting set the exact timetable.
In may last year, the United States independent judges have abolished jury award $6.5 million for takeda has ruled that the plaintiff failed to provide the Actos has caused any credible evidence of cancer.
In recent cases, said lanier, the jury, only 10 minutes to 1 hour, to provide for all 14 topic sentence for 45 minutes the legal responsibility, and billions of dollars more punitive damages.
The jury also ordered in a suit to pay $1475000 in damages.
At present, the case in heavy: Actos product liability litigation, the United States district court for the western state of Louisiana, 11 - MD - 2299.
